Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of D-EC skin test antigen for diagnosis of Mycobacterium tuberculosis infection in people aged 3 years and older in China
CTR20253234Phase 3Active
- Sponsor
- Cansino Beijing
- Start
- Aug 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of C-Tb in Tuberculosis (TB), sponsored by Cansino Beijing. Started Aug 2025; status: active.
02
Drugs
C-Tb
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on CTR20253234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253234.